US Patent 11078472 Recombinant clostridial neurotoxins with increased duration of effect
Patent 11078472 was granted and assigned to Merz Pharma on August, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11078472 Recombinant clostridial neurotoxins with increased duration of effect
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
